← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Snowdon Pharmaceuticals, Inc.
Monmouth Junction, NJ
$884,497
Total funding
3
Grants
Funding over time
peak $316.9K · FY2008–10$500K$375K$250K$125K$0
'08
'09
'10
Funding mix
By agency
NIH$884,497 · 3
By mechanism
R43$884,497 · 3
Investigators at Snowdon Pharmaceuticals, Inc.
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
Not enough data
All-Time
Most funded here, all years
Largest grants
Development of an Inhibitor of Toxoplasma gondii$316,916
R43 · FY2010 · AI
Development of an Inhibitor of Toxoplasma gondii$311,662
R43 · FY2009 · AI
Targeted Aggregation Inhibitors for the Treatment of Amyloid Diseases$132,948
R43 · FY2008 · NS
COMPUTER-AIDED DESIGN, SYNTHESIS, AND TESTING OF A NOVEL FAMILY OF TRIAZOLE-BASED$122,971
R43 · FY2008 · CA